Dichtl Anna, Jamin Daniela, Stöver Heino, Grabski Meryem, Knorr Bärbel
Institut für Suchtforschung, Frankfurt University of Applied Sciences, Nibelungenplatz 1, 60318, Frankfurt am Main, Deutschland.
Deutsche Aidshilfe, Berlin, Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Jan;67(1):36-44. doi: 10.1007/s00103-023-03808-y. Epub 2023 Dec 28.
Despite general advances in the treatment of people with hepatitis C in Germany, it is unclear to what extent this also applies to specific key populations, such as prisoners.
In a short survey conducted in June 2021, the ministries of justice in the federal states were asked about data collection and diagnostic methods as well as the prevalence of infections caused by the hepatitis C virus (HCV) and HCV treatment among prisoners in Germany. In addition, expert interviews were conducted regarding HCV treatment barriers and missed opportunities in prisons.
It is evident that there is no complete and comprehensive data collection within the ministries of justice. Prevention measures, such as opiate substitution therapy in prison, are available in all participating federal states. More specific offers and measures (e.g., razor and syringe exchange) are only found in a few cases and are sometimes subject to a charge. Experts point out that although treatment in prison generally complies with the equivalence principle: it is more difficult to reach the target group.
Comprehensive education and counselling on HCV treatment, consistent HCV testing and treatment, and preventive measures to avoid (re-)infection are important for successful HCV elimination in prisons.
尽管德国丙型肝炎患者的治疗取得了总体进展，但尚不清楚这在多大程度上也适用于特定的关键人群，如囚犯。
在2021年6月进行的一项简短调查中，向联邦各州的司法部询问了德国囚犯中丙型肝炎病毒（HCV）感染及HCV治疗的数据收集、诊断方法以及患病率。此外，就监狱中HCV治疗的障碍和错失的机会进行了专家访谈。
显然，司法部内部没有完整和全面的数据收集。所有参与的联邦州都有预防措施，如监狱中的阿片类药物替代疗法。更具体的服务和措施（如剃须刀和注射器交换）仅在少数情况下存在，有时还需收费。专家指出，虽然监狱中的治疗总体上符合等效原则，但更难接触到目标群体。
关于HCV治疗的全面教育和咨询、持续的HCV检测和治疗以及避免（再）感染的预防措施对于监狱中成功消除HCV至关重要。
